FDA grapples with gray areas in fast-tracking experimental drugs
Gray areas create agonizing conundrums for agency officials and patient advocates.
Experimental Ebola treatment given to Americans, but when will regulatory pathway extend to sick Africans?
The two Ebola-infected Americans recently evacuated from Liberia were given an experimental drug that probably saved their lives, but Popular Science raises an interesting point – no Africans are likely to get the same treatment. Not anytime soon, that is. Kent Brantly and Nancy Writebol, the two volunteers in an Ebola clinic that contracted the deadly virus, […]
Why Pharma Companies Should Look To Social Media For Better Patient Insight
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.